Corporate Information And Statement Of Ifrs Compliance [Abstract]

BerGenBio - Filing #2615544

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	BerGenBio ASA	—
Domicile of entity	—	Norway	—
Legal form of entity	—	limited public liability	—
Country of incorporation	—	Norway	—
Address of entity's registered office	—	Jonas Lies vei 91, 5009 Bergen, Norway	—
Principal place of business	—	Norway	—
Description of nature of entity's operations and principal activities	—	clinical-stage	—
Name of parent entity	—	BerGenBio ASA	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade payables	26,726,000 NOK	—	22,550,000 NOK